Jinquan Cai
Jinquan Cai
Harbin Medical University
Dirección de correo verificada de hrbmu.edu.cn
Título
Citado por
Citado por
Año
CGCG clinical practice guidelines for the management of adult diffuse gliomas
T Jiang, Y Mao, W Ma, Q Mao, Y You, X Yang, C Jiang, C Kang, X Li, ...
Cancer letters 375 (2), 263-273, 2016
1712016
Long noncoding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT/β-catenin pathway by scaffolding EZH2
Q Chen, J Cai, Q Wang, Y Wang, M Liu, J Yang, J Zhou, C Kang, M Li, ...
Clinical Cancer Research 24 (3), 684-695, 2018
1012018
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
W Cheng, X Ren, C Zhang, J Cai, Y Liu, S Han, A Wu
Neurology 86 (24), 2226-2234, 2016
682016
ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole …
J Cai, P Yang, C Zhang, W Zhang, Y Liu, Z Bao, X Liu, W Du, H Wang, ...
Oncotarget 5 (9), 2551, 2014
562014
Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness
W Du, X Liu, L Chen, Z Dou, X Lei, L Chang, J Cai, Y Cui, D Yang, Y Sun, ...
Neuro-oncology 17 (2), 243-253, 2015
542015
Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas
P Yang, J Cai, W Yan, W Zhang, Y Wang, B Chen, G Li, S Li, C Wu, K Yao, ...
Neuro-oncology 18 (8), 1099-1108, 2016
512016
Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo …
X Liu, X Wang, W Du, L Chen, G Wang, Y Cui, Y Liu, Z Dou, H Wang, ...
Oncotarget 5 (22), 11681, 2014
512014
Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma
H Wang, T Tao, W Yan, Y Feng, Y Wang, J Cai, Y You, T Jiang, C Jiang
Scientific reports 5 (1), 1-11, 2015
472015
Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance
J Cai, W Zhang, P Yang, Y Wang, M Li, C Zhang, Z Wang, H Hu, Y Liu, ...
PloS one 10 (5), 2015
422015
Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors
J Cai, J Chen, W Zhang, P Yang, C Zhang, M Li, K Yao, H Wang, Q Li, ...
Oncotarget 6 (20), 18105, 2015
402015
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
J Li, J Cai, S Zhao, K Yao, Y Sun, Y Li, L Chen, R Li, X Zhai, J Zhang, ...
Journal of experimental & clinical cancer research 35 (1), 184, 2016
372016
Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
J Cai, P Zhu, C Zhang, Q Li, Z Wang, G Li, G Wang, P Yang, J Li, B Han, ...
Oncotarget 7 (13), 16384, 2016
362016
A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
W Cheng, X Ren, J Cai, C Zhang, M Li, K Wang, Y Liu, S Han, A Wu
Oncotarget 6 (30), 29285, 2015
362015
Evolving molecular genetics of glioblastoma
QJ Li, JQ Cai, CY Liu
Chinese medical journal 129 (4), 464, 2016
302016
Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples
G Li, Z Wang, C Zhang, X Liu, J Cai, Z Wang, H Hu, F Wu, Z Bao, Y Liu, ...
Oncoimmunology 6 (8), e1328339, 2017
292017
Comparative analysis of matrix metalloproteinase family members reveals that MMP9 predicts survival and response to temozolomide in patients with primary glioblastoma
Q Li, B Chen, J Cai, Y Sun, G Wang, Y Li, R Li, Y Feng, B Han, J Li, Y Tian, ...
PLoS One 11 (3), 2016
292016
Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
F Wu, C Zhang, J Cai, F Yang, T Liang, X Yan, H Wang, W Wang, J Chen, ...
Oncotarget 8 (32), 53110, 2017
272017
ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
J Cai, C Zhang, W Zhang, G Wang, K Yao, Z Wang, G Li, Z Qian, Y Li, ...
Oncoscience 3 (7-8), 2016
262016
Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling
CB Zhang, P Zhu, P Yang, JQ Cai, ZL Wang, QB Li, ZS Bao, W Zhang, ...
Oncotarget 6 (34), 36643, 2015
252015
Recent advances in targeted therapy for glioma.
JC Lin L, Cai J
Curr Med Chem, 2016
24*2016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20